FDA Inspection 1109451 — Blood Bank Of Delmarva, A Division Of New York Blood Center, Inc.

Blood Bank Of Delmarva, A Division Of New York Blood Center, Inc. — FEI 3010954917

The FDA completed an inspection of Blood Bank Of Delmarva, A Division Of New York Blood Center, Inc. on Nov 12, 2019 in Hyattsville, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 12, 2019
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Hyattsville, MD (United States)

Citations

IDCFRDescription
202621 CFR 211.192Quality control unit review of records
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.